During a 4-day pause of fighting in an ongoing conflict, 306,000 Yemenis, including 164,000 children under the age of 15, were vaccinated with the cholera vaccine, according to an update today from the World Health Organization (WHO).
Massachusetts General Hospital (MGH) said today it was part of an international multisite study evaluating ZMapp, an experimental Ebola treatment. ZMapp contains three antibodies and is being used in the current outbreak in the Democratic Republic of the Congo (DRC)
US Department of Agriculture (USDA) officials have confirmed a second outbreak of low-pathogenic H7N3 avian flu in a California turkey flock in the same county—Stanislaus—as one reported a week ago, according to a World Organization for Animal Health (OIE) report yesterday.
Saudi Arabia yesterday reported three more MERS-CoV cases, including two from different cities who contracted the virus from a sick household contact.
Kuwait's health ministry said yesterday that an investigation so far hasn't turned up any evidence to suggest that a South Korean business traveler who was diagnosed with MERS-CoV (Middle East respiratory syndrome coronavirus) after returning to his home country was exposed in Kuwait, the Korea Times reported today.
In an unusual development, the United Kingdom today reported a second monkeypox case just 3 days after announcing its first case, but so far the investigation doesn't show a link between the two patients, Public Health England (PHE) said today in a statement.
The United Kingdom's National Institute for Health and Care Excellence (NICE) today issued draft guidance for the treatment of urinary tract infections (UTIs).
In response to cholera outbreaks in several African countries over the past several months, the World Health Organization (WHO) today announced the largest cholera vaccination drive in history, with a goal of reaching 2 million people.
Rain, war, and other factors have helped create the largest cholera outbreak in history, researchers say.
A 2-year follow-up study of the single-dose oral cholera vaccine (OCV) showed it was effective in adults and children over the age of 5 years. Consistent with results from the 6-month follow-up, the vaccine failed to protect children under the age of 5 from the disease.